Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT India 2025

Coronary Sinus Reducer

Presenter: Ajar Kochar

July 26, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Todd Neale

November 11, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased

Michael O'Riordan

May 05, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

Advertisement

Coronary Sinus Reducer

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

AHA Statement Outlines Cardiac Contributions to Brain Health

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content